White Paper
Beyond Compliance: How to create a robust postmarket surveillance program that cuts costs while enhancing performance.
Postmarket Surveillance
Jul 04, 2022
Download

Postmarket Surveillance is the keystone of a strong vigilance program. It ensures that even after a medical device is released into the market, developers continue to monitor its safety and effectiveness in the real world. Activities range from reactive reviews of complaints and adverse events, to proactive tracking of device performance via customer surveys, interviews and focus groups.

This process ensures medical devices perform as expected, and provide opportunities to improve future iterations. However, it's a costly and time-consuming aspect of the life sciences operation, and demands on postmarket surveillance teams continue to increase.

Related solutions

Contact Us